TrialScientific reports2014

Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients.

Annamaria Ruzzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.